SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

NCT05770687 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Diabetes Mellitus, Type 2

Interventions

DRUG: SGLT2 inhibitor

Sponsor

Kiyuk Chang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]